Wound Heal

0
Pipeline Programs
4
Companies
7
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

ConvaTec
ConvaTecNJ - Bridgewater
4 programs
EDX110N/A1 trial
InnovaMatrix® ACN/A1 trial
InnovaMatrix® ACN/A1 trial
innovaMatrix ACN/A1 trial
Active Trials
NCT07209358RecruitingEst. Dec 2026
NCT06606210RecruitingEst. Apr 2026
NCT06616844RecruitingEst. Jul 2026
+1 more trials
C
ColoplastAustralia - Mulgrave
1 program
Biatain AgN/A1 trial
Active Trials
NCT05923749CompletedEst. Jan 2025
Tempo Therapeutics
Tempo TherapeuticsCA - San Diego
1 program
MAP Wound MatrixN/A1 trial
Active Trials
NCT06600152Active Not RecruitingEst. Aug 2026
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Wound HealingN/A1 trial
Active Trials
NCT03204851Unknown100Est. Dec 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ConvaTecEDX110
ConvaTecInnovaMatrix® AC
ConvaTecInnovaMatrix® AC
Tempo TherapeuticsMAP Wound Matrix
ConvaTecinnovaMatrix AC
ColoplastBiatain Ag
Mission TherapeuticsWound Healing

Clinical Trials (7)

Total enrollment: 100 patients across 7 trials

EDX110 Randomized Control Trial for Treatment of DFUs

Start: Oct 2025Est. completion: Dec 2026
N/ARecruiting
NCT06616844ConvaTecInnovaMatrix® AC

IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers

Start: Feb 2025Est. completion: Jul 2026
N/ARecruiting
NCT06606210ConvaTecInnovaMatrix® AC

INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone

Start: Sep 2024Est. completion: Apr 2026
N/ARecruiting

Safety of Microporous Annealed Particle (MAP) Wound Matrix in Patients With Clean Surgical Wounds.

Start: Aug 2024Est. completion: Aug 2026
N/AActive Not Recruiting
NCT07170566ConvaTecinnovaMatrix AC

A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre

Start: May 2024Est. completion: Aug 2025
N/ACompleted

A RCT Evaluating the Clinical Benefit of a Silver Dressing in the Treatment of Venous Leg Ulcers

Start: Jun 2023Est. completion: Jan 2025
N/ACompleted

Microlyte Dressing in the Management of Wounds

Start: Oct 2016Est. completion: Dec 2020100 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 actively recruiting trials targeting 100 patients
4 companies competing in this space